$HCIL
Hongchang International Co., Ltd Stock $hcil

$hcil Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000121390024028792 Filed on April 01, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$18.20K		$2.676M
YoY Change	79.86%		3289.09%
Cost Of Revenue	$18.48K		$2.606M
YoY Change	1491.47%		9417.73%
Gross Profit	-$273.00		$69.36K
YoY Change	-103.05%		34.5%
Gross Profit Margin	-1.5%		2.59%
Selling, General & Admin	$102.0K		$538.9K
YoY Change	-35.2%		69.82%
% of Gross Profit			777.03%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$22.06K		$88.17K
YoY Change	-2.82%		-4.54%
% of Gross Profit			127.13%
Operating Expenses	$102.0K		$538.9K
YoY Change	-35.2%		69.82%
Operating Profit	-$102.3K		-$469.6K
YoY Change	-31.11%		76.68%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$147.00		$44.00
YoY Change	12.21%		-78.0%
Pretax Income	-$102.0K		-$444.7K
YoY Change	-31.26%		67.45%
Income Tax	-$5.426K		-$65.91K
% Of Pretax Income
Net Earnings	-$96.57K		-$378.8K
YoY Change	-34.92%		42.63%
Net Earnings / Revenue	-530.48%		-14.16%
Basic Earnings Per Share	$0.00		$0.00
Diluted Earnings Per Share	$0.00		$0.00
COMMON SHARES
Basic Shares Outstanding	518.8M shares	518.8M shares	450.2M shares
Diluted Shares Outstanding	518.8M shares		450.2M shares

Balance Sheet

Concept	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$895.1K	$895.7K
Short-Term Investments
Other Short-Term Assets	$1.133M	$1.142M
YoY Change	35976.91%	36398.69%
Inventory	$164.00	$13.71K
Prepaid Expenses	$3.266K	$23.32K
Receivables	$4.375K	$742.9K
Other Receivables	$1.757K	$1.107M
Total Short-Term Assets	$2.034M	$3.961M
YoY Change	3496.89%	12123.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.854K	$3.193K
YoY Change	-98.52%
Goodwill
YoY Change
Intangibles	$3.069K	$3.213K
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.886M	$706.9K
YoY Change	43402.94%
Total Long-Term Assets	$51.42M	$46.25M
YoY Change	24846.6%
TOTAL ASSETS
Total Short-Term Assets	$2.034M	$3.961M
Total Long-Term Assets	$51.42M	$46.25M
Total Assets	$53.45M	$50.22M
YoY Change	20249.8%	154867.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$317.1K	$385.8K
YoY Change	72.95%	35.33%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$347.3K	$1.055M
YoY Change	-84.74%	-47.37%
LONG-TERM LIABILITIES
Long-Term Debt	$5.954M
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$13.53M	$8.672M
YoY Change	11954.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$347.3K	$1.055M
Total Long-Term Liabilities	$13.53M	$8.672M
Total Liabilities	$13.87M	$9.728M
YoY Change	480.86%	385.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$909.1K	-$812.5K
YoY Change	-95.46%	-95.91%
Common Stock	$518.8K	$518.8K
YoY Change	-49.75%	-49.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$39.58M	$40.49M
YoY Change
Total Liabilities & Shareholders Equity	$53.45M	$50.22M
YoY Change	20249.8%	154867.19%

Cashflow Statement

Concept	2024 Q1	2023
OPERATING ACTIVITIES
Net Income	-$96.57K	-$378.8K
YoY Change	-34.92%	42.63%
Depreciation, Depletion And Amortization	$22.06K	$88.17K
YoY Change	-2.82%	-4.54%
Cash From Operating Activities	$9.718K	$750.5K
YoY Change	-103.32%	-356.76%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$5.045M	-$41.68M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$5.053M	$40.94M
YoY Change	1528.44%	20740.19%
NET CHANGE
Cash From Operating Activities	$9.718K	$750.5K
Cash From Investing Activities	-$5.045M	-$41.68M
Cash From Financing Activities	$5.053M	$40.94M
Net Change In Cash	-$656.00	$892.6K
YoY Change	-103.69%	12462.83%
FREE CASH FLOW
Cash From Operating Activities	$9.718K	$750.5K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	450231897	shares
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-26731
CY2023	dei	Entity Registrant Name EntityRegistrantName	Hongchang International Co., Ltd
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0627910
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	Block 20
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Hongchang Food Co., Ltd., Yuanhong Investment Zone
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	Donggao Village
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Fuzhou City
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	350300
CY2023	dei	Entity Address Country EntityAddressCountry	CN
CY2023	dei	City Area Code CityAreaCode	(86)
CY2023	dei	Local Phone Number LocalPhoneNumber	180 5901 6050
CY2023	dei	Security12b Title Security12bTitle	None
CY2023	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	197698530	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	518831367	shares
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Name AuditorName	WWC, P.C.
CY2023	dei	Auditor Firm AuditorFirmId	1171
CY2023	dei	Auditor Location AuditorLocation	San Mateo, California
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	895730	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3141	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	742851	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1106574	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	13713	usd
CY2023Q4	hcil	Advance To Supplierrelated Party AdvanceToSupplierrelatedParty	59324	usd
CY2022Q4	hcil	Advance To Supplierrelated Party AdvanceToSupplierrelatedParty	60885	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1142409	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	18989	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	3960742	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	83015	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	3193	usd
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	41423399	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	26837950	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3213	usd
CY2023Q4	hcil	Land Use Right Net Non Current LandUseRightNetNonCurrent	4118101	usd
CY2022Q4	hcil	Land Use Right Net Non Current LandUseRightNetNonCurrent	4316604	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	706920	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	46254826	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	31154554	usd
CY2023Q4	us-gaap	Assets Assets	50215568	usd
CY2022Q4	us-gaap	Assets Assets	31237569	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	650905	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	5677	usd
CY2023Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	18493	usd
CY2022Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	25249414	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	385805	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3553	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1055203	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	25258644	usd
CY2023Q4	hcil	Deferred Subsidies Current DeferredSubsidiesCurrent	1989463	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	8672422	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	6397578	usd
CY2023Q4	us-gaap	Liabilities Liabilities	9727625	usd
CY2022Q4	us-gaap	Liabilities Liabilities	31656222	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	518831367	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	518831367	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	415582375	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	415582375	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	518831	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	415582	usd
CY2022Q4	hcil	Subscription Receivable SubscriptionReceivable	415582	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	39905228	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-812539	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-433745	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	876423	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	15092	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	40487943	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-418653	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	50215568	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31237569	usd
CY2023	us-gaap	Revenues Revenues	2675789	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	2606431	usd
CY2023	us-gaap	Gross Profit GrossProfit	69358	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	28	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	538902	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	239992	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	538930	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	239992	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-469572	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-239992	usd
CY2023	us-gaap	Interest Income Operating InterestIncomeOperating	1386	usd
CY2022	us-gaap	Interest Income Operating InterestIncomeOperating	18	usd
CY2023	us-gaap	Other Income OtherIncome	23531	usd
CY2023	us-gaap	Other Expenses OtherExpenses	44	usd
CY2022	us-gaap	Other Expenses OtherExpenses	15	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-444699	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-239989	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-65905	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-378794	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-239989	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	861331	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	15092	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	482537	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-224897	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	450231897	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61674985	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-193756	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-239989	usd
CY2022	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	15092	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-418653	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-418653	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-378794	usd
CY2023	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	861331	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	41241108	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-817049	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	40487943	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-378794	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-239989	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	88173	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	92367	usd
CY2023	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	23249	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-65905	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	743377	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	13723	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	4218	usd
CY2022	hcil	Increase Decrease Advance From Customer IncreaseDecreaseAdvanceFromCustomer	62427	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1058798	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	18502	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	645831	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4393	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	313708	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1616	usd
CY2023	hcil	Increase Decrease Deferred Subsidies IncreaseDecreaseDeferredSubsidies	1990873	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	750521	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-225774	usd
CY2023	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	40596144	usd
CY2022	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	1555438	usd
CY2023	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse	3297	usd
CY2023	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	141	usd
CY2023	hcil	Payments To Fund Longterm Loans To Third Party PaymentsToFundLongtermLoansToThirdParty	1079891	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-41679473	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1555438	usd
CY2023	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	41241108	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	3199390	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	2900289	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1781932	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	40942007	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1781932	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	879534	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-224	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	892589	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	496	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3141	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2645	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	895730	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3141	usd
CY2023Q4	hcil	Share Capital Issued And Outstanding ShareCapitalIssuedAndOutstanding	518831367	shares
CY2023Q4	us-gaap	Common Unit Issued CommonUnitIssued	415582375	shares
CY2023Q4	hcil	Percentage Of Share Capital PercentageOfShareCapital	0.801	pure
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>(c) Use of estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, related disclosures of contingent assets and liabilities at the balance sheet date, and the reported revenue and expenses during the reported period in the consolidated financial statements and accompanying notes. Significant accounting estimates reflected in the Group’s consolidated financial statements mainly include, but are not limited to, assessment for impairment of long-lived assets, valuation of deferred tax assets and current expected credit loss of receivables. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Management bases the estimates on historical experience and on various other assumptions as discussed elsewhere to the consolidated financial statements that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. On an ongoing basis, management evaluates its estimates based on information that is currently available. Changes in circumstances, facts and experience may cause the Group to revise its estimates. Changes in estimates are recorded in the period in which they become known. Actual results could materially differ from these estimates.</span></p>
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	7.0798	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	6.8983	usd
CY2023	us-gaap	Payments For Other Deposits PaymentsForOtherDeposits	72000	usd
CY2023	us-gaap	Payments For Other Deposits PaymentsForOtherDeposits	500000	cny
CY2023Q4	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P3Y
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2023Q4	hcil	Deferred Subsidies Current DeferredSubsidiesCurrent	1989463	usd
CY2023	hcil	Number Of Customers NumberOfCustomers	1	pure
CY2023Q2	hcil	Capital Contribution CapitalContribution	41241108	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	pure
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-812539	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-378794	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	41241108	usd
CY2023Q2	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	60000000	cny
CY2023Q2	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	8500000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	742851	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	742851	usd
CY2023Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	1079127	usd
CY2023Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	27447	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1106574	usd
CY2023Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	1079127	usd
CY2023Q4	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	1039421	usd
CY2022Q4	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	18989	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	65858	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	23319	usd
CY2023Q4	us-gaap	Supplies Supplies	13811	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1142409	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	18989	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	188	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3193	usd
CY2023	us-gaap	Depreciation Depreciation	188	usd
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	41423399	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	26837950	usd
CY2023Q4	hcil	Construction In Progress Net ConstructionInProgressNet	41423399	usd
CY2022Q4	hcil	Construction In Progress Net ConstructionInProgressNet	26837950	usd
CY2023Q4	us-gaap	Area Of Land AreaOfLand	130000	sqm
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	3295	usd
CY2023Q4	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	82	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3213	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	82	usd
CY2023Q4	hcil	Land Use Rights LandUseRights	4388808	usd
CY2022Q4	hcil	Land Use Rights LandUseRights	4504282	usd
CY2023Q4	hcil	Less Accumulated Amortization LessAccumulatedAmortization	270707	usd
CY2022Q4	hcil	Less Accumulated Amortization LessAccumulatedAmortization	187678	usd
CY2023Q4	hcil	Land Use Right Net LandUseRightNet	4118101	usd
CY2022Q4	hcil	Land Use Right Net LandUseRightNet	4316604	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	706920	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	706920	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	706920	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	92262	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	2464	usd
CY2023Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	239543	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	54000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1089	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	385805	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3553	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-65905	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-65905	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.0034	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.038	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.25	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.2085	pure
CY2023Q4	hcil	Deferred Tax Assetsland Use Right Amortization DeferredTaxAssetslandUseRightAmortization	65858	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	318355	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	215824	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	252497	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	215824	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	65858	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	420000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	370000	usd
CY2023Q1	us-gaap	Shares Outstanding SharesOutstanding	100	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	1	usd
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	100	shares
CY2023	us-gaap	Subsidiary Or Equity Method Investee Cumulative Number Of Shares Issued For All Transactions SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssuedForAllTransactions	100	shares
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	100	shares
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	100	shares
CY2023Q1	us-gaap	Shares Issued SharesIssued	415582375	shares
CY2023Q1	us-gaap	Subsidiary Or Equity Method Investee Cumulative Number Of Shares Issued For All Transactions SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssuedForAllTransactions	100	shares
CY2023Q2	us-gaap	Other Additional Capital OtherAdditionalCapital	41241108	usd
CY2023Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	100	shares
CY2023Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	415582375	shares
CY2023Q2	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	60000000	cny
CY2023	us-gaap	Assets Average Outstanding AssetsAverageOutstanding	18492173	usd
CY2022	us-gaap	Assets Average Outstanding AssetsAverageOutstanding	46517560	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent		usd
CY2022Q4	us-gaap	Inventory Net InventoryNet		usd
CY2022Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther		usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2022Q4	hcil	Deferred Subsidies Current DeferredSubsidiesCurrent		usd
CY2023Q4	hcil	Subscription Receivable SubscriptionReceivable		usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2022	us-gaap	Gross Profit GrossProfit		usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense		usd
CY2022	us-gaap	Other Income OtherIncome		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61674985	shares
CY2022	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables		usd
CY2023	hcil	Increase Decrease Advance From Customer IncreaseDecreaseAdvanceFromCustomer		usd
CY2022	hcil	Increase Decrease Deferred Subsidies IncreaseDecreaseDeferredSubsidies		usd
CY2022	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse		usd
CY2022	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties		usd
CY2022	hcil	Payments To Fund Longterm Loans To Third Party PaymentsToFundLongtermLoansToThirdParty		usd
CY2022	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates		usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense		usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense		usd
CY2022Q4	hcil	Deferred Subsidies Current DeferredSubsidiesCurrent		usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent		usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet		usd
CY2022Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties		usd
CY2022Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent		usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent		usd
CY2023Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent		usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet		usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent		usd
CY2022Q4	us-gaap	Supplies Supplies		usd
CY2022	us-gaap	Depreciation Depreciation		usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets		usd
CY2022	us-gaap	Impairment Charge On Reclassified Assets ImpairmentChargeOnReclassifiedAssets		usd
CY2023	us-gaap	Impairment Charge On Reclassified Assets ImpairmentChargeOnReclassifiedAssets		usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense		pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent		pure
CY2022Q4	hcil	Deferred Tax Assetsland Use Right Amortization DeferredTaxAssetslandUseRightAmortization		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023Q2	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	8500000	usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001086303

Files In Submission

Name	View Source	Status
0001213900-24-028792-index-headers.html	Edgar Link	pending
0001213900-24-028792-index.html	Edgar Link	pending
0001213900-24-028792.txt	Edgar Link	pending
0001213900-24-028792-xbrl.zip	Edgar Link	pending
ea0201030-10k_hong.htm	Edgar Link	pending
ea020103001ex14-1_hongchang.htm	Edgar Link	pending
ea020103001ex19-1_hongchang.htm	Edgar Link	pending
ea0201030-10k_hong_htm.xml	Edgar Link	completed
ea020103001ex21-1_hongchang.htm	Edgar Link	pending
ea020103001ex31-1_hongchang.htm	Edgar Link	pending
ea020103001ex31-2_hongchang.htm	Edgar Link	pending
ea020103001ex32-1_hongchang.htm	Edgar Link	pending
ea020103001ex32-2_hongchang.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hcil-20231231.xsd	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
hcil-20231231_cal.xml	Edgar Link	unprocessable
hcil-20231231_def.xml	Edgar Link	unprocessable
hcil-20231231_lab.xml	Edgar Link	unprocessable
hcil-20231231_pre.xml	Edgar Link	unprocessable
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HCIL
Hongchang International Co., Ltd Stock $hcil

2024 Q1 Form 10-K Financial Statement

#000121390024028792 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HCIL Hongchang International Co., Ltd Stock $hcil

2024 Q1 Form 10-K Financial Statement

#000121390024028792 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HCIL
Hongchang International Co., Ltd Stock $hcil